Ofer Goldberg
Economics and Finance
Clal Industries
Israel
Biography
For the past fifteen years, Ofer Goldberg has been actively involved with healthcare related companies ranging in stage from inception to commercialization. Ofer is responsible for strategic investment decisions and technological development of CBI. Ofer is also the managing director of Anatomy Medical Technology fund, CBI’s medical device investment arm. Ofer Goldberg serves as an executive chairman and board member of several biotech and medical device companies, among them Biocancell (TASE: BICL), Curetech, Pi-Cardia, Cologuard, Biokine and SightDX. Ofer Goldberg holds an M.A. in Economics and Finance from Tel Aviv University and a B.Sc. in Physics and Mathematics from the Hebrew University of Jerusalem.
Research Interest
Physics and Mathematics
